Notably, CLU mRNA levels were highly correlated with reduced NADPH oxidase activity and negative regulation of ferroptosis in HNSCC (Fig. 6C), indicating that CLU potentially reduces ROS production in cancer cells. The gene discussed is FMO5; the disease is cancer.